DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Miskowiak KW, Vinberg M, Christensen EM. et al.
Recombinant human erythropoietin for treating treatment-resistant depression: A double-blind, randomized, placebo-controlled phase 2 trial.
Neuropsychopharmacology 2014;
39: 1399-1408
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.